MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, NVAX has $1,176,512K in assets. $1,304,265K in debts. $240,634K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
212.69%
Quick Ratio
210.18%
Cash Ratio
52.32%
Debt to Asset Ratio
110.86%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Goodwill
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Total current liabilities
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
240,634
Marketable securities
494,450
Restricted cash
10,876
Accounts receivable
106,446
Inventory
11,545
Prepaid expenses and other current assets
26,815
Assets held for sale
87,510
Total current assets
978,276
Property and equipment, net
44,800
Right-of-use asset, net
22,897
Goodwill
113,462
Other non-current assets
17,077
Total assets
1,176,512
Accounts payable
24,578
Accrued expenses
107,165
Deferred revenue
140,053
Current portion of finance lease liabilities
2,507
Other current liabilities
137,778
Liabilities held for sale
47,869
Total current liabilities
459,950
Deferred revenue
358,943
Convertible notes payable
244,213
Non-current finance lease liabilities
2,091
Other non-current liabilities
239,068
Total liabilities
1,304,265
Common stock, 0.01 par value, 600,000,000 shares authorized at december31, 2025 and 2024 and 164,969,773 shares issued and 162,575,937 shares outstanding at december31, 2025 and 161,942,677 shares issued and 160,421,136 shares outstanding at december31, 2024
1,650
Additional paid-in capital
4,539,756
Accumulated deficit
-4,568,148
Treasury stock, 2,393,836 shares, cost basis at december31, 2025 and 1,521,541 shares, cost basis at december31, 2024
103,021
Accumulated other comprehensive income (loss)
2,010
Total stockholders deficit
-127,753
Total liabilities and stockholders deficit
1,176,512
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$494,450K Cash and cashequivalents$240,634K Accounts receivable$106,446K Assets held for sale$87,510K Prepaid expenses andother current assets$26,815K Inventory$11,545K Restricted cash$10,876K Total current assets$978,276K Goodwill$113,462K Property and equipment,net$44,800K Right-of-use asset, net$22,897K Other non-currentassets$17,077K Total assets$1,176,512K Accumulated deficit-$4,568,148K Treasury stock,2,393,836 shares, cost...$103,021K Total liabilities andstockholders deficit$1,176,512K Total stockholdersdeficit-$127,753K Additional paid-in capital$4,539,756K Accumulated othercomprehensive income (loss)$2,010K Common stock, 0.01 parvalue, 600,000,000...$1,650K Total liabilities$1,304,265K Total currentliabilities$459,950K Deferred revenue$358,943K Convertible notes payable$244,213K Other non-currentliabilities$239,068K Non-current finance leaseliabilities$2,091K Deferred revenue$140,053K Other currentliabilities$137,778K Accrued expenses$107,165K Liabilities held for sale$47,869K Accounts payable$24,578K Current portion offinance lease...$2,507K

NOVAVAX INC (NVAX)

NOVAVAX INC (NVAX)